ATE542830T1 - Als gerüst verwendeter ob-fold zur entwicklung neuer spezifischer bindemittel - Google Patents

Als gerüst verwendeter ob-fold zur entwicklung neuer spezifischer bindemittel

Info

Publication number
ATE542830T1
ATE542830T1 AT06291869T AT06291869T ATE542830T1 AT E542830 T1 ATE542830 T1 AT E542830T1 AT 06291869 T AT06291869 T AT 06291869T AT 06291869 T AT06291869 T AT 06291869T AT E542830 T1 ATE542830 T1 AT E542830T1
Authority
AT
Austria
Prior art keywords
scaffold
development
new specific
specific binders
fold used
Prior art date
Application number
AT06291869T
Other languages
English (en)
Inventor
Frederic Pecorari
Pedro Alzari
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE542830T1 publication Critical patent/ATE542830T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1041—Ribosome/Polysome display, e.g. SPERT, ARM
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyurethanes Or Polyureas (AREA)
AT06291869T 2006-12-04 2006-12-04 Als gerüst verwendeter ob-fold zur entwicklung neuer spezifischer bindemittel ATE542830T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06291869A EP1930342B1 (de) 2006-12-04 2006-12-04 Als Gerüst verwendeter OB-Fold zur Entwicklung neuer spezifischer Bindemittel

Publications (1)

Publication Number Publication Date
ATE542830T1 true ATE542830T1 (de) 2012-02-15

Family

ID=37964126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06291869T ATE542830T1 (de) 2006-12-04 2006-12-04 Als gerüst verwendeter ob-fold zur entwicklung neuer spezifischer bindemittel

Country Status (12)

Country Link
US (4) US20100145008A1 (de)
EP (3) EP1930342B1 (de)
JP (3) JP2010511691A (de)
CN (2) CN101652386B (de)
AT (1) ATE542830T1 (de)
AU (1) AU2007330409B2 (de)
CA (1) CA2671553C (de)
DK (1) DK2099817T3 (de)
ES (2) ES2536509T3 (de)
IL (1) IL199057A (de)
MX (1) MX2009005949A (de)
WO (1) WO2008068637A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2653752A1 (en) 2006-05-26 2007-12-06 Vickery Laurence Arcus Ob fold domains
US20090304719A1 (en) 2007-08-22 2009-12-10 Patrick Daugherty Activatable binding polypeptides and methods of identification and use thereof
RU2636046C2 (ru) 2009-01-12 2017-11-17 Сайтомкс Терапьютикс, Инк Композиции модифицированных антител, способы их получения и применения
AU2010215761B2 (en) 2009-02-23 2017-04-06 Cytomx Therapeutics, Inc Proproteins and methods of use thereof
SG179200A1 (en) * 2009-09-16 2012-04-27 Univ Massey Fusion polypeptides and uses thereof
EP2341079A1 (de) 2009-12-23 2011-07-06 Institut Pasteur Immunoglobulinbindende Proteine, die aus Sac7d abgeleitet wurden, und deren Verwendungen
EP2469278A1 (de) 2010-12-21 2012-06-27 Institut Pasteur Reagenzlose fluoreszente Biosensoren von Nanofitins, rationelle Designmethoden zur Erzeugung von reagenzlosen fluoreszenten Biosensoren, und ihre Einsatzmethoden
FR2974816A1 (fr) 2011-05-04 2012-11-09 Centre Nat Rech Scient Methode de generation de proteines
WO2014103203A1 (ja) 2012-12-27 2014-07-03 独立行政法人産業技術総合研究所 微小タンパク質の骨格構造に基づく分子ライブラリ
FR3004650B1 (fr) * 2013-04-22 2015-05-29 Affilogic Composition topique comprenant un variant d'une protéine sauvage à pli-OB, ainsi que son procédé de préparation
EP2955196A1 (de) 2014-06-10 2015-12-16 Effimune Gegen CD127 gerichtete Antikörper
JP6655074B2 (ja) 2014-06-20 2020-02-26 ジェネンテック， インコーポレイテッド シャガシンに基づく足場組成物、方法及び使用
FR3027521B1 (fr) * 2014-10-24 2016-12-16 Affilogic Compositions pour administration par voie orale
WO2016172485A2 (en) 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
WO2017149394A1 (en) 2016-02-29 2017-09-08 Ose Immunotherapeutics Non-antagonistic antibodies directed against the alpha chain of the il7 receptor extracellular domain and use thereof in cancer treatment
IL262251B2 (en) 2016-04-14 2023-09-01 Ose Immunotherapeutics New anti-syrap antibodies and their medical applications
EP3509616A1 (de) 2016-09-09 2019-07-17 H. Hoffnabb-La Roche Ag Selektive peptidinhibitoren des frizzled
JP7179743B2 (ja) 2017-02-17 2022-11-29 オーエスイー・イミュノセラピューティクス 抗ＳＩＲＰｇ抗体の新規の使用
EP3434692A1 (de) 2017-07-24 2019-01-30 Encefa Verbindungen mit spezifischer bindung an cd38 zur verwendung bei der behandlung von neurodegenerativen krankheiten
EP3694881A1 (de) 2017-10-13 2020-08-19 OSE Immunotherapeutics Modifizierte anti-sirpa-antikörper und verwendungen davon
EP3483180A1 (de) * 2017-11-14 2019-05-15 Affilogic Multispezifische moleküle
US11714090B2 (en) 2017-12-15 2023-08-01 Syngenta Participations Ag Non-antibody ligands for detecting target proteins
JP2021517130A (ja) 2018-03-13 2021-07-15 オーセ イミュノセラピューティクスＯｓｅ Ｉｍｍｕｎｏｔｈｅｒａｐｅｕｔｉｃｓ 抗ヒトＳＩＲＰａｖ１抗体の使用および抗ｖ１抗体を製造する方法
IL321209A (en) 2018-04-03 2025-07-01 Ose Immunotherapeutics Anti-chemokin like receptor 1 antibodies and their medical uses
US20230242640A1 (en) 2018-08-22 2023-08-03 Ose Immunotherapeutics ANTI-SIRPg Compounds
EP3632924A1 (de) * 2018-10-07 2020-04-08 Affilogic Bindemittel zur hemmung der bildung von multimeren proteinen
WO2020127369A1 (en) 2018-12-21 2020-06-25 Ose Immunotherapeutics Bifunctional molecule directed against human pd-1
SG11202107941TA (en) 2019-01-23 2021-08-30 Encefa Cd31 competitors and uses thereof
BR112021021673A2 (pt) 2019-05-09 2021-12-21 Genentech Inc Método para melhorar o emparelhamento preferencial de uma cadeia pesada e uma cadeia leve de um anticorpo e anticorpo
WO2020231504A1 (en) 2019-05-16 2020-11-19 Massachusetts Institute Of Technology Glycan-binding proteins and related compositions and methods
PH12022550844A1 (en) 2019-10-09 2023-06-14 Ose Immunotherapeutics Anti-chemokin like receptor 1 humanized antibodies and their therapeutic applications
EP4077368A1 (de) * 2019-12-18 2022-10-26 Bracco Imaging SPA Anti-her2-polypeptidderivate als neue diagnostische molekulare sonden
WO2021122726A1 (en) * 2019-12-18 2021-06-24 Bracco Imaging Spa Anti-her2 polypeptides derivatives as new diagnostic molecular probes
EP3878858A1 (de) * 2020-03-11 2021-09-15 Affilogic Sac7d varianten und deren verwendung zur behandlung von krebs
GB202019817D0 (en) * 2020-12-15 2021-01-27 Univ Oxford Innovation Ltd Ligand-binding polypeptides and uses thereof
US12428457B2 (en) * 2021-01-29 2025-09-30 University Of South Florida Cold-shock protein scaffold for engineering non-antibody binding proteins
EP4043481A1 (de) * 2021-02-15 2022-08-17 Affilogic Verbindungen und verfahren zur verlängerung der halbwertszeit von biomolekülen
CN117597353A (zh) * 2021-03-18 2024-02-23 艾菲洛之克公司 抗因子c3的sac7d变体及其治疗补体介导疾患的医疗用途
US20250145673A1 (en) * 2021-03-18 2025-05-08 Affilogic Polypeptides for complement inhibition
EP4308590A1 (de) 2021-03-18 2024-01-24 Affilogic Antifaktor-c3-sak7d-varianten und ihre medizinische verwendung zur behandlung von komplementvermittelten erkrankungen
EP4059949A1 (de) 2021-03-18 2022-09-21 Affilogic Anti-faktor c3 sac7d-varianten und ihre medizinische verwendung zur behandlung komplementvermittelter störungen
CN114787465A (zh) * 2021-09-16 2022-07-22 日立环球生活方案株式会社 无尘室设施
EP4190358A1 (de) 2021-12-05 2023-06-07 Affilogic Polypeptid als träger für die durchquerung von darmbarrieren
WO2023140360A1 (ja) * 2022-01-20 2023-07-27 京都府公立大学法人 抗体模倣分子
TW202448509A (zh) 2023-05-12 2024-12-16 美商建南德克公司 減少抗體黏度之方法及組成物
WO2025073890A1 (en) 2023-10-06 2025-04-10 Institut National de la Santé et de la Recherche Médicale Method to capture circulating tumor extracellular vesicles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264963B1 (en) 1995-08-18 2007-09-04 Morphosys Ag Protein(poly)peptide libraries
WO1998008839A1 (en) 1996-08-26 1998-03-05 Eli Lilly And Company Combinatorial process for preparing substituted thiophene libraries
US6794144B1 (en) 1999-05-26 2004-09-21 Licentia Ltd. Methods and materials for generating SH3 domains with tailored binding properties
AU5114000A (en) * 2000-06-14 2001-12-24 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
EP2141243A3 (de) * 2000-10-16 2010-01-27 Brystol-Myers Squibb Company Proteingerüste für Antikörpermimetika und andere Bindungsproteine
US7560260B2 (en) * 2002-07-25 2009-07-14 Bio-Rad Laboratories, Inc. Compositions with polymerase activity
US7666645B2 (en) * 2002-10-23 2010-02-23 Bio-Rad Laboratories, Inc. Sso7-polymerase conjugate proteins
AU2004225520A1 (en) * 2003-03-25 2004-10-14 Stratagene DNA polymerase fusions and uses thereof
US7462490B2 (en) 2003-10-31 2008-12-09 Chevron Oronite Company Llc Combinatorial lubricating oil composition libraries
JP2007537716A (ja) * 2003-12-16 2007-12-27 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼイション サイトカイン結合ドメイン
GB0416651D0 (en) * 2004-07-26 2004-08-25 Proteo Target Aps Polypeptide
EP1836223B1 (de) * 2005-01-03 2011-11-23 F. Hoffmann-La Roche AG Methode zur Identifizierung einer Nukeinsäure kodierend für eine Hemopexin-ähnliche Struktur mit spezifischer Bindung zu einem vorgegebenen Molekul
GB0500099D0 (en) * 2005-01-05 2005-02-09 Cambridge Antibody Tech Methods and means relating to protein variants
CA2653752A1 (en) * 2006-05-26 2007-12-06 Vickery Laurence Arcus Ob fold domains
EP1892248A1 (de) 2006-08-21 2008-02-27 Eidgenössische Technische Hochschule Zürich Bindeproteine mit spezifischer und hoher Affinität enthaltend modifizierte SH3-Domänen von FYN-Kinasen

Also Published As

Publication number Publication date
IL199057A (en) 2016-02-29
CN101652386B (zh) 2013-03-20
US20160010083A1 (en) 2016-01-14
EP2570424A1 (de) 2013-03-20
JP2018035139A (ja) 2018-03-08
US20200181601A1 (en) 2020-06-11
MX2009005949A (es) 2009-06-30
EP2099817A2 (de) 2009-09-16
JP6253496B2 (ja) 2017-12-27
EP2099817B1 (de) 2015-02-11
ES2602782T3 (es) 2017-02-22
CN103145812A (zh) 2013-06-12
EP2570424B1 (de) 2016-09-28
EP1930342B1 (de) 2012-01-25
WO2008068637A2 (en) 2008-06-12
CN101652386A (zh) 2010-02-17
US20170166887A1 (en) 2017-06-15
US20100145008A1 (en) 2010-06-10
AU2007330409B2 (en) 2013-04-18
HK1141304A1 (en) 2010-11-05
DK2099817T3 (en) 2015-05-18
WO2008068637A3 (en) 2008-10-30
JP2010511691A (ja) 2010-04-15
EP1930342A1 (de) 2008-06-11
CA2671553C (en) 2017-09-05
JP6684761B2 (ja) 2020-04-22
US9422548B2 (en) 2016-08-23
JP2014169304A (ja) 2014-09-18
US11434585B2 (en) 2022-09-06
HK1117548A1 (en) 2009-01-16
AU2007330409A1 (en) 2008-06-12
ES2536509T3 (es) 2015-05-26
CA2671553A1 (en) 2008-06-12
US10584330B2 (en) 2020-03-10

Similar Documents

Publication Publication Date Title
ATE542830T1 (de) Als gerüst verwendeter ob-fold zur entwicklung neuer spezifischer bindemittel
DK1984517T3 (da) Fremgangsmåde til modulering af rekombinante proteiners mannoseindhold
DK2275542T3 (da) Fremgangsmåde til identifikation af nyttige proteiner i bryggerigær
BRPI0709598A8 (pt) composições de polipeptídeos estabilizados
EP2780460A4 (de) Modifizierte dna-bindende proteine und verwendungen davon
ATE533859T1 (de) MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN
EP2064336A4 (de) Interleukin-13-bindende proteine
EP1991273A4 (de) Markierung und detektion von posttranslational modifizierten proteinen
NZ597756A (en) Method for purifying recombinant adamts13 and other proteins and compositions thereof
ATE540114T1 (de) Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle
CR10775A (es) Proteinas de dedo de zin no canonicas optimizadas
MA33213B1 (fr) Anticorps antagoniste specifique d'un heterodimere alpha-4-beta-7
DK3381933T3 (da) Muteiner af hngal og relaterede proteiner med affinitet til et givet mål
EP2193145A4 (de) Zusammensetzungen und verfahren mit bindungsproteinen für adalimumab
EP2185574A4 (de) An 24p4c12-proteine bindende antikörper und zugehörige moleküle
EP2262837A4 (de) Pd-1-bindende proteine
DE602007012175D1 (de) Verfahren und System zur Postsortierung umfassend das Sortieren von Bildern der Poststücke
DE602005012856D1 (de) Verfahren, Computerprogramm und System zur regulieren von E-mail
WO2007092579A3 (en) Compositions and methods for capturing and analyzing cross-linked biomolecules
FI20051248L (fi) Biologisten komponenttien rikastusyksikkö ja rikastusmenetelmä
FI20050727L (fi) Vieraiden hiukkasten tribologinen analyysijärjestelmä
DE602005012555D1 (de) Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon
DE602005008370D1 (de) Dateiserver und Verfahren zur Umsetzung von Benutzerkennung
MX341064B (es) Variantes de la familia il-1.
ATE483018T1 (de) Neue fluoreszenzproteine und verfahren zur verwendung davon